Orthopedics
Transgenomic to Present at Rodman & Renshaw 13th Annual Healthcare Conference
September 7, 2011 12:39 pm | by Bio-Medicine.Org | News | CommentsOMAHA, Neb., Sept. 7, 2011 /- Transgenomic, Inc. (OTC/BB: TBIO) today announced that Craig Tuttle, President and Chief Executive Officer of Transgenomic, will be presenting at the Rodman & Renshaw 13th Annual Healthcare Conference on Tuesday, September 13th at 11:40 AM Eastern Time at...
Lupin Receives Final Approval to Market Generic Ultram® ER
August 31, 2011 11:41 am | by Bio-Medicine.Org | News | CommentsBALTIMORE, Aug. 31, 2011 /- Lupin Pharmaceuticals, Inc. (LPI) today announced that it has received final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Tramadol Hydrochloride Extended-Release Tablets, 100, 200...
Small Town Company Thrives Against All Odds
August 31, 2011 11:40 am | by Bio-Medicine.Org | News | CommentsSIERRA MADRE, Calif., Aug. 31, 2011 /- In the quaint little town of Sierra Madre, one budding business just joined the ranks of companies such as Microsoft and Oracle. By helping hospitals all over the country, Wound Care Advantage has reached #316 on Inc. Magazine's "500" list of the...
Verathon® Introduces the Heartscape™ 3D ECG System with 80-Lead Vest in Europe; Technology Provides More Complete Data to Help Diagnose Acute Myocardial Infarction (MI)
August 19, 2011 3:48 am | by Bio-Medicine.Org | News | CommentsBOTHELL, Wash., Aug. 19, 2011 /- Verathon Inc. is pleased to introduce in Europe the Heartscape™ 3D ECG System with 80-lead vest, designed to give Emergency Department (ED) physicians, Interventional Cardiologists, and ED nurses a more complete diagnostic picture by providing a 360...
Cardium Announces Receipt of $1.1 Million in Funds from Philips' Acquisition of Innercool Therapies
August 18, 2011 5:50 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO, Aug. 18, 2011 /- Cardium Therapeutics (NYSE Amex: CXM ) today reported that it had received funds corresponding to the final $1.1 million payment from Royal Philips Electronics in connection with Philips' acquisition of Innercool Therapies from Cardium. The release of...
REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation
August 18, 2011 5:50 am | by Bio-Medicine.Org | News | CommentsMILFORD, Mass., Aug. 18, 2011 /- PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced that final results from the REMEDIAL II investigator-sponsored clinical trial of RenalGuard® in Italy have been published on-line in...
Levosimendan - Comprehensive Patent Search
August 17, 2011 3:43 am | by Bio-Medicine.Org | News | CommentsNEW YORK, Aug. 17, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Levosimendan - Comprehensive patent search...
Echo Therapeutics Announces Second Quarter 2011 Financial Results
August 12, 2011 4:45 am | by Bio-Medicine.Org | News | CommentsPHILADELPHIA, Aug. 12, 2011 /- Echo Therapeutics, Inc. (Nasdaq: ECTE ), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System for transdermal drug...
Ruby+Associates Completes Latest Mercy Health Systems Design-Build Project
August 9, 2011 7:46 am | by Bio-Medicine.Org | News | CommentsFARMINGTON HILLS, Mich., Aug. 9, 2011 /- Ruby+Associates, the constructability-focused structural engineering firm, has completed its design-build assignment for Mercy Health Systems' Willard Hospital project in Willard, OH. Ruby acted as the engineer of record on the 105,000 sq ft...
MANSFIELD, Mass., Aug 04, 2011 (BUSINESS WIRE)
August 4, 2011 8:39 pm | by Covidien | News | CommentsMANSFIELD, Mass., Aug 04, 2011 (BUSINESS WIRE) --Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that the first patients have been enrolled in the DURABILITY(TM) Iliac and VISIBILITY(TM) Iliac studies. Dr. Marc Bosiers, at AZ ...
CytoSorbents Corporation to Exhibit at the Advanced Technology Applications for Combat Casualty Care Conference
August 4, 2011 4:44 am | by Bio-Medicine.Org | News | CommentsMONMOUTH JUNCTION, N.J., Aug. 4, 2011 /- CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company using blood purification to treat life-threatening illnesses, announced that it is exhibiting at the Advanced Technology Applications for Combat Casualty Care (ATACCC)...
IMD Announces 35% Increase in Revenues for OMI
August 2, 2011 9:42 am | by Bio-Medicine.Org | News | CommentsTAMPA, Fla., Aug. 2, 2011 /- IMD Companies Inc. announces that when it files its Second Quarter Financial Reports with OTC Markets, LLC, the reports will reflect a 35% increase in revenues for Integrated Medical Diagnostics (Integrated) and Optimum Mobile Imaging (OMI) bringing the year...
New IOF-ISCD review clarifies the use of FRAX in clinical practice
August 2, 2011 12:46 am | by International Osteoporosis Foundation | News | CommentsDetails strengths and limitations of the tool, provides recommendations for using surrogate country models
Resurrection Medical Center First in Chicago - 8th in the World - to Offer 128-Slice PET/CT Scanner Technology
July 26, 2011 6:38 am | by Bio-Medicine.Org | News | CommentsCHICAGO, July 26, 2011 /PRNewswire-USNewswire/ -- Patients at Resurrection Medical Center (RMC), part of Resurrection Health Care , in Chicago can now receive non-invasive, whole-body PET/CT scans in just minutes. The first of its kind in the Chicago area, and 8th in the world, the new...
CAP Announces Advanced Digital Technology for 2012 Programs
July 26, 2011 6:38 am | by Bio-Medicine.Org | News | CommentsNORTHFIELD, Ill., July 26, 2011 /PRNewswire-USNewswire/ -- Today, the College of American Pathologists (CAP) will introduce online imaging technology, DigitalScope, for use in its laboratory proficiency testing (Surveys) programs in 2012 at the 2011 AACC (American Association for Clinical...
Free Delivery on All Health Care Products
July 24, 2011 12:42 pm | by Bio-Medicine.Org | News | CommentsSHENZHEN, China, July 24, 2011 /PRNewswire-Asia/ -- Benefited by the convenience and health brought by series of health care products, more and more people are inclined to further purchase relative products for their friends as gifts, and for their families as an indispensable device to...
Stereotaxis to Report Second Quarter 2011 Financial Results and Conduct Conference Call on August 8, 2011
July 20, 2011 3:41 am | by Bio-Medicine.Org | News | CommentsST. LOUIS, July 20, 2011 /- Stereotaxis, Inc. (NASDAQ: STXS ) today announced that it will release financial results for the second quarter ended June 30, 2011 on Monday, August 8, 2011 after the close of the U.S. financial markets. The Company will host a conference call and...
Daiichi Sankyo Launches LIXIANA® (edoxaban), a Direct Oral Factor Xa Inhibitor, in Japan for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery
July 19, 2011 6:48 am | by Bio-Medicine.Org | News | CommentsTOKYO, July 19, 2011 /- Building on its cardiovascular portfolio, Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo), is proud to announce the launch of LIXIANA® (JAN: Edoxaban Tosilate Hydrate, INN: edoxaban) in Japan. This announcement follows the first marketing approval...
Medical Device Consultants, Inc. Welcomes Brian Edwards, Senior Regulatory Staff Consultant
July 19, 2011 6:47 am | by Bio-Medicine.Org | News | CommentsNORTH ATTLEBORO, Mass., July 19, 2011 /- Medical Device Consultants, Inc. (MDCI), a leading regulatory consulting firm and CRO for the medical device industry, announced today that Mr. Brian Edwards has joined the company's regulatory services group as a senior regulatory staff...
Abaxis to Report First Quarter Fiscal Year 2012 Financial Results Thursday, July 28, 2011
July 19, 2011 6:47 am | by Bio-Medicine.Org | News | CommentsUNION CITY, Calif., July 19, 2011 /- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the first quarter of fiscal year 2012, ended June 30, 2011. The call will...
Jonah and Dina Shacknai Issue Statement Regarding the Release of Paradise Valley Police Reports
July 19, 2011 1:41 am | by Bio-Medicine.Org | News | CommentsSCOTTSDALE, Ariz., July 19, 2011 /- Jonah and Dina Shacknai today issued the following statement in response to media inquiries related to the release of police reports by the Paradise Valley Police Department: While our marriage did not work out as either of us had hoped, it did produce...
World Healthcare UPS Markets
July 19, 2011 1:41 am | by Bio-Medicine.Org | News | CommentsNEW YORK, July 19, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: World Healthcare UPS Markets...
North American External Defibrillator Market
July 19, 2011 1:41 am | by Bio-Medicine.Org | News | CommentsNEW YORK, July 19, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: North American External Defibrillator Market...
New Data Showed Minimal Potential for Drug Interaction Between Cholesterol Drug LIVALO® and a Common Antiretroviral Therapy
July 18, 2011 2:42 am | by Bio-Medicine.Org | News | CommentsMONTGOMERY, Ala. and INDIANAPOLIS, July 18, 2011 /- Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company (NYSE: LLY ) today released new study results that investigated the potential interaction of cholesterol drug LIVALO (pitavastatin) 4 mg in healthy volunteers taking the...
A Heart Pump without a Cord
July 17, 2011 8:43 pm | by Massachusetts Institute of Technology | News | CommentsA new wireless power scheme could make implanted devices more comfortable, and reduce the risk of infection.
